pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda press·5h ago·1 min read
save

FDA launches nationwide recruitment to broaden scientific and consumer representation on advisory committees

Sep 30, 2026·read at fda press ↗RegulatoryPositive

The U.S. Food and Drug Administration announced a new nationwide effort to recruit qualified experts and consumer representatives for its advisory committees. The agency issued two Federal Register notices: one to fill voting member vacancies with scientific, technical, and professional experts, and another to add consumer voices to ensure public input.

Acting FDA Commissioner Kyle Diamantas highlighted that the panels bring together leading scientific minds to address complex public‑health questions. The recruitment drive seeks clinicians, researchers, and community members who can contribute the latest science and real‑world experience.

The initiative is presented as a way to strengthen the partnership between the FDA and the nation’s brightest minds, reinforcing the agency’s commitment to science‑based, transparent regulation.

source

This writeup was produced by pharmadog from original reporting by fda press.

Original headline: “FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees”

read at fda press ↗
603 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2
topics
AdCom2Vaccines2CardiologyNeurologyOncology

related stories

  • 7h agoNovo, BioMarin, Enanta dole out pink slipsBioSpace
  • Sep 22New federal autism committee head has financial ties to leucovorinSTAT
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 27RFK Jr. said a Samoa trip had nothing to do with vaccines. New documents refute thatSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive